Woodline Partners LP

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1784547 San Francisco, CA

Position in SUPN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$23,208,603

-$37,188,924 QoQ

Shares Held

448,996

-64.5% QoQ

Ownership

0.774%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $139,051,923 across 13 Drug Manufacturers - Specialty & Generic names. SUPN ranks #2 (16.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	1,163,863	$35,055,553
2	SUPN	Supernus Pharmaceuticals, Inc. This page	448,996	$23,208,603
3	ALKS	Alkermes plc.	558,567	$19,750,929
4	PBH	Prestige Consumer Healthcare Inc.	273,943	$16,236,601
5	VTRS	Viatris Inc	1,167,948	$15,778,977
6	AMLX	Amylyx Pharmaceuticals, Inc.	845,800	$11,756,620
7	ETON	Eton Pharmaceuticals, Inc.	170,699	$4,212,851
8	LQDA	Liquidia Corp	100,160	$3,780,038

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$23,208,603	448,996	-64.5%	Shares	Sole	2026-05-15
2025-09-30	$60,397,527	1,263,811	+63.5%	Shares	Sole	2025-11-14
2025-06-30	$24,364,203	772,976	+82.4%	Shares	Sole	2025-08-14
2024-12-31	$15,325,620	423,828	+124.8%	Shares	Sole	2025-02-14
2024-09-30	$5,879,643	188,571	-85.4%	Shares	Sole	2024-11-14
2024-03-31	$44,045,936	1,291,291	+1119.6%	Shares	Sole	2024-05-15
2022-12-31	$3,776,668	105,878	-86.7%	Shares	Sole	2023-02-14
2022-09-30	$26,869,012	793,767	+39.6%	Shares	Sole	2022-11-14
2022-06-30	$16,443,304	568,579	+17.1%	Shares	Sole	2022-08-15
2022-03-31	$15,688,515	485,412	+800.3%	Shares	Sole	2022-05-16
2021-09-30	$1,437,913	53,915	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.